Literature DB >> 19913863

Enhanced CD4+ cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection.

Jessica Wade1, Jasminka Sterjovski, Lachlan Gray, Michael Roche, Lisa Chiavaroli, Anne Ellett, Martin R Jakobsen, Daniel Cowley, Candida da Fonseca Pereira, Nitin Saksena, Bin Wang, Damian F J Purcell, Ingrid Karlsson, Eva-Maria Fenyö, Melissa Churchill, Paul R Gorry.   

Abstract

CCR5-using (R5) human immunodeficiency virus type 1 (HIV-1) strains cause CD4+ T-cell loss in most infected individuals, but mechanisms underlying cytopathicity of R5 viruses are poorly understood. We investigated mechanisms contributing to R5 envelope glycoprotein (Env)-mediated cellular apoptosis by constructing a panel of retroviral vectors engineered to co-express GFP and R5 Envs derived from two HIV-1-infected subjects spanning asymptomatic (Early, E-R5 Envs) to late stages of infection (Late, L-R5 Envs). The L-R5 Envs induced significantly more cellular apoptosis than E-R5 Envs, but only in Env-expressing (GFP-positive) cells, and only in cells where CD4 and CCR5 levels were limiting. Studies with fusion-defective Env mutants showed induction of apoptosis required membrane-fusing events. Our results provide evidence for an intracellular mechanism of R5 Env-induced apoptosis of CD4+ cells that requires membrane fusion. Furthermore, they contribute to a better understanding of mechanisms involved in CD4+ T-cell loss in subjects experiencing progressive R5 HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913863     DOI: 10.1016/j.virol.2009.10.029

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

Review 1.  Coreceptors and HIV-1 pathogenesis.

Authors:  Paul R Gorry; Petronela Ancuta
Journal:  Curr HIV/AIDS Rep       Date:  2011-03       Impact factor: 5.071

2.  Genetic signatures of HIV-1 envelope-mediated bystander apoptosis.

Authors:  Anjali Joshi; Raphael T C Lee; Jonathan Mohl; Melina Sedano; Wei Xin Khong; Oon Tek Ng; Sebastian Maurer-Stroh; Himanshu Garg
Journal:  J Biol Chem       Date:  2013-11-21       Impact factor: 5.157

3.  HIV-1 escape from the CCR5 antagonist maraviroc associated with an altered and less-efficient mechanism of gp120-CCR5 engagement that attenuates macrophage tropism.

Authors:  Michael Roche; Martin R Jakobsen; Jasminka Sterjovski; Anne Ellett; Filippo Posta; Benhur Lee; Becky Jubb; Mike Westby; Sharon R Lewin; Paul A Ramsland; Melissa J Churchill; Paul R Gorry
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

4.  An altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes.

Authors:  Jasminka Sterjovski; Michael Roche; Melissa J Churchill; Anne Ellett; William Farrugia; Lachlan R Gray; Daniel Cowley; Pantelis Poumbourios; Benhur Lee; Steven L Wesselingh; Anthony L Cunningham; Paul A Ramsland; Paul R Gorry
Journal:  Virology       Date:  2010-06-08       Impact factor: 3.616

5.  Efficiency of CCR5 coreceptor utilization by the HIV quasispecies increases over time, but is not associated with disease progression.

Authors:  Andrew D Redd; Oliver Laeyendecker; Xiangrong Kong; Noah Kiwanuka; Tom Lutalo; Wei Huang; Ronald H Gray; Maria J Wawer; David Serwadda; Susan H Eshleman; Thomas C Quinn
Journal:  AIDS Res Hum Retroviruses       Date:  2011-08-05       Impact factor: 2.205

Review 6.  Targeting HIV-1 gp41-induced fusion and pathogenesis for anti-viral therapy.

Authors:  Himanshu Garg; Mathias Viard; Amy Jacobs; Robert Blumenthal
Journal:  Curr Top Med Chem       Date:  2011-12       Impact factor: 3.295

7.  Raltegravir blocks the infectivity of red-fluorescent-protein (mCherry)-labeled HIV-1JR-FL in the setting of post-exposure prophylaxis in NOD/SCID/Jak3-/- mice transplanted with human PBMCs.

Authors:  Hiromi Ogata-Aoki; Nobuyo Higashi-Kuwata; Shin-Ichiro Hattori; Hironori Hayashi; Matthew Danish; Manabu Aoki; Chiemi Shiotsu; Yumi Hashiguchi; Akinobu Hamada; Hisataka Kobayashi; Hironobu Ihn; Seiji Okada; Hiroaki Mitsuya
Journal:  Antiviral Res       Date:  2017-09-08       Impact factor: 5.970

8.  HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients.

Authors:  Anjali Joshi; Melina Sedano; Bethany Beauchamp; Erin B Punke; Zuber D Mulla; Armando Meza; Ogechika K Alozie; Debabrata Mukherjee; Himanshu Garg
Journal:  J Immunol       Date:  2016-01-13       Impact factor: 5.422

9.  Single amino acid change in gp41 region of HIV-1 alters bystander apoptosis and CD4 decline in humanized mice.

Authors:  Himanshu Garg; Anjali Joshi; Chunting Ye; Premlata Shankar; N Manjunath
Journal:  Virol J       Date:  2011-01-21       Impact factor: 4.099

Review 10.  HIV-1 induced bystander apoptosis.

Authors:  Himanshu Garg; Jonathon Mohl; Anjali Joshi
Journal:  Viruses       Date:  2012-11-09       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.